Denosumab

Results: 175



#Item
101Microsoft Word - Prolia REMS w-MG, CP Approval cleared.doc

Microsoft Word - Prolia REMS w-MG, CP Approval cleared.doc

Add to Reading List

Source URL: courses.washington.edu

Language: English - Date: 2010-07-05 02:13:16
102Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.fdhc.state.fl.us

Language: English - Date: 2012-06-25 14:43:19
103Dear Healthcare Professional Letter of Rapid Safety Communication September 2012 RANMARK SUBCUTANEOUS INJECTION 120mg (denosumab) -Risk of severe hypocalcaemia, including fatal cases 11 September 2012 Dear Healthcare P

Dear Healthcare Professional Letter of Rapid Safety Communication September 2012 RANMARK SUBCUTANEOUS INJECTION 120mg (denosumab) -Risk of severe hypocalcaemia, including fatal cases 11 September 2012 Dear Healthcare P

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2012-09-12 05:48:19
104U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
105U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
106Microsoft Word - Appendix D

Microsoft Word - Appendix D

Add to Reading List

Source URL: www.osteoporosis.ca

Language: English - Date: 2013-10-18 01:45:39
107U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
108Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Office of Safety I, Pharmaceuticals and Medical Devices Agency

Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Office of Safety I, Pharmaceuticals and Medical Devices Agency

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2013-06-09 22:47:34
109Severe hypocalcaemia fatal cases where the causal relationship to RANMARK (denosumab) cannot be ruled out  No. 1 (non-small

Severe hypocalcaemia fatal cases where the causal relationship to RANMARK (denosumab) cannot be ruled out No. 1 (non-small

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2012-09-13 04:24:32
110Clinician’s Guide to Prevention and Treatment of Osteoporosis

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Add to Reading List

Source URL: nof.org

Language: English - Date: 2014-05-12 15:45:16